Fundraising FoxAponia Laboratories
Hampton, US · Founded 2010 · Delaware corporation
Find your way into Aponia Laboratories
Sign up to see every warm intro you have to Aponia Laboratories
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aponia Laboratories team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Aponia Laboratories is a specialized pharmaceutical company developing topical prescription and over-the-counter pain relief products based on ibuprofen for the NSAID segment of the arthritis pain market. Its products have completed formulation development and non-clinical studies and are undergoing FDA-guided clinical trials.
Founders & leadership
Aponia Laboratories was founded in 2010 by Kenneth M. Corroon and Robert J. Boolbol, M.D..
KM
Kenneth M. CorroonCo-founder, Chairman & CEO
RJ
Robert J. Boolbol, M.D.Co-founder & Director
EB
Elizabeth BoolbolExecutive
Board
DR
Daniel R McLeodBoard director
VK
VIKESH KUMARBoard director
RB
Robert BoolbolBoard director
JW
JEAN-PAUL WIENENBoard director
DB
David B McKaneBoard director
AK
Abhaya Kumar JainBoard director
Reported raises · per SEC filings
Form D private placements$3.7M disclosed across 5 of 6 rounds · 2012–2026
▶Undisclosed amountofferedSep 2026 · OtherRule 506(b)
▶Undisclosed amountofferedSep 2026 · Other
Rule 506(b)Officers, directors & promoters on the filing
- KENNETH M CORROONExecutive Officer, Director
- ROBERT BOOLBOLDirector
- DANIEL R MCLEODDirector
- JEAN-PAUL WIENENDirector
- VIKESH KUMARDirector
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$507.5KraisedApr 2025 · 2 investors · PharmaceuticalsRule 506(b)
▶$507.5KraisedApr 2025 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- DANIEL R MCLEODDirector
- VIKESH KUMARDirector
- ROBERT BOOLBOLDirector
- JEAN-PAUL WIENENDirector
- KENNETH M CORROONExecutive Officer, Director
- DAVID B MCKANEDirector
- Offering amount
- $507.5K
- Amount sold
- $507.5K
- Minimum investment
- $10K
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$35KraisedOct 2021 · 1 investors · PharmaceuticalsRule 506(b)
▶$35KraisedOct 2021 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Vikesh KumarDirector
- David B McKaneDirector
- Robert BoolbolDirector
- Kenneth M CorroonExecutive Officer, Director
- Daniel R McLeodDirector
- Offering amount
- $35K
- Amount sold
- $35K
- Minimum investment
- $35K
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedMar 2015 · 2 investors · PharmaceuticalsRule 506(b)
▶$1.2MraisedMar 2015 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Daniel R McLeodDirector
- Robert BoolbolDirector
- David B McKaneDirector
- Abhaya Kumar JainDirector
- Kenneth M CorroonExecutive Officer, Director
- Offering amount
- $3.8M
- Amount sold
- $1.2M
- Proceeds to insiders
- $75K
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
▶$1.5MraisedOct 2014 · 8 investors · PharmaceuticalsRule 506(b)
▶$1.5MraisedOct 2014 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kenneth CorroonExecutive Officer, Director
- Offering amount
- $3.9M
- Amount sold
- $1.5M
- Proceeds to insiders
- $65K
- First sale
- Oct 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
▶$460KraisedMar 2012 · 4 investors · PharmaceuticalsRule 506(b)
▶$460KraisedMar 2012 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Elizabeth BoolbolExecutive Officer
- Kenneth CorroonExecutive Officer, Director
- David McKaneDirector
- Robert BoolbolDirector
- Offering amount
- $1.8M
- Amount sold
- $460K
- Proceeds to insiders
- $40K
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Johnson & JohnsonJohnson & Johnson develops prescription medicines and medical technology across areas including oncology, immunology, neuroscience, cardiopulmonary, cardiovascular, orthopaedics, surgery, and vision. Its two main businesses, Innovative Medicine and MedTech, focus on treating complex diseases through science-based drugs and less invasive, personalized medical devices.
Eli LillyEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.
Companies working in the same space as Aponia Laboratories.
Frequently asked questions
- What does Aponia Laboratories do?
- Aponia Laboratories is a specialized pharmaceutical company developing topical prescription and over-the-counter pain relief products based on ibuprofen for the NSAID segment of the arthritis pain market. Its products have completed formulation development and non-clinical studies and are undergoing FDA-guided clinical trials.
- Who founded Aponia Laboratories?
- Aponia Laboratories was founded by Kenneth M. Corroon, Robert J. Boolbol, M.D. in 2010.
- How much funding has Aponia Laboratories raised?
- Aponia Laboratories has disclosed $3.7M raised across 5 of its 6 known rounds.
- Where is Aponia Laboratories headquartered?
- Aponia Laboratories is headquartered in Hampton, US.